Hemodynamic Effects During Land vs Water Exercise for Older Adults With Orthostatic Hypotension

Sponsor
University of Texas at Austin (Other)
Overall Status
Recruiting
CT.gov ID
NCT05233865
Collaborator
(none)
20
1
2
12.4
1.6

Study Details

Study Description

Brief Summary

The purpose of the study is to understand how blood pressure, heart rate, and symptoms of low blood pressure (such as dizziness or nausea) are affected by positional changes and exercise when on land or in the water for people who tend to experience dizziness upon standing.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Water exercise
  • Behavioral: Land exercise
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Hemodynamic Effects During Land vs Water Exercise for Older Adults With Orthostatic Hypotension
Actual Study Start Date :
Oct 19, 2021
Anticipated Primary Completion Date :
Oct 31, 2022
Anticipated Study Completion Date :
Oct 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Water condition

Participants blood pressure, heart rate and self-reported symptoms (such as dizziness) will be collected multiple times during sitting, standing and walking conditions when in a pool.

Behavioral: Water exercise
Participants will be asked to sit and stand multiple times (before, immediately after, and 2 hours after a 15-minute walking session). The walking session will consist of 3 minutes of walking at a light intensity followed by 9 min of walking at a moderate intensity and a 3-minute cool down walking at a light intensity. This walking session will occur in a pool.

Active Comparator: Land condition

Participants blood pressure, heart rate and self-reported symptoms (such as dizziness) will be collected multiple times during sitting, standing, and walking conditions when on land.

Behavioral: Land exercise
Participants will be asked to sit and stand multiple times (before, immediately after, and 2 hours after a 15-minute walking session). The walking session will consist of 3 minutes of walking at a light intensity followed by 9 min of walking at a moderate intensity and a 3-minute cool down walking at a light intensity. This walking session will occur on land.

Outcome Measures

Primary Outcome Measures

  1. Systolic blood pressure (mmHg) [<1 minute upon standing]

    Blood pressure will be taken with an automated blood pressure device

  2. Diastolic blood pressure (mmHg) [<1 minute upon standing]

    Blood pressure will be taken with an automated blood pressure device

  3. Self-reported orthostatic hypotension symptoms [2 minutes]

    A self-reported instrument assessing symptoms from low blood pressure experienced upon standing or after prolonged upright activities. Possible scores range from 0 (no symptoms) to 10 (worse possible symptoms)

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Self-report of dizziness upon standing (from sit or supine position) or known diagnosis of orthostatic hypotension

  • Able to stand independently for 3-5 consecutive minutes

  • Able to walk independently (with or without an assistive devise)

  • Medically stable for last month

  • Score of 3 or greater on Mini-Cog (standardized outcome measure to detect dementia)

  • Full coronavirus vaccination

Exclusion Criteria:
  • Diagnosis of dementia

  • Contraindication for pool exercise (such as infected open wounds, fecal incontinence, diarrhea.)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cardiovascular Aging Research Laboratory at UT Austin Austin Texas United States 78712

Sponsors and Collaborators

  • University of Texas at Austin

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Texas at Austin
ClinicalTrials.gov Identifier:
NCT05233865
Other Study ID Numbers:
  • STUDY00001869
First Posted:
Feb 10, 2022
Last Update Posted:
Feb 10, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 10, 2022